Last Updated May 6, 2017 11:22 AM EDT
The White House is pushing back against criticism over a proposed 95 percent cut to the budget of the Office of National Drug Control Policy (ONDCP), arguing the federal government remains committed to fighting the opioid epidemic.
In a draft version of a budget memo, the Office of Management and Budget (OMB) proposed cutting nearly half the staff in the “Druz Czar” office in fiscal year 2018 (FY18), as well as a number of grant programs and other agency functions.
One of ONDCP’s grant programs funds the nation’s largest drug prevention program, supporting 5,000 local anti-drug community efforts across the country. The program has enjoyed widespread support from members of both parties.
At the White House briefing on Friday, deputy press secretary Sarah Sanders told reporters that she wasn’t going to get ahead of budget conversations, but claimed that the opioid epidemic is “a top priority” for Mr. Trump.
John Czwartacki, the OMB communications director, told CBS News that the FY18 budget is still under review and not a finalized document.
“Reports that suggest budgetary numbers or policy decisions are premature and subject to change before the late May publication of the budget,” he wrote in an email.
A senior administration official suggested that if the White House decided to strip ONDCP of it’s agency mandate to coordinate collaboration between federal and local law enforcement and public health organizations, transitioning it into an office like the National Security Council or National Economic Council. The official said cuts would “by no means signal the commitment to winning the war on drugs is lessened.”
The senior administration official pointed to dozens of drug programs across many federal agencies as evidence that the White House is committed to anti-drug efforts, even if the ONDCP loses its ability to issue grants.